PUBLISHER: IMARC | PRODUCT CODE: 1451545
PUBLISHER: IMARC | PRODUCT CODE: 1451545
Insomnia Market Report by Therapy Type, Drug Class, Distribution Channel, and Region 2024-2032
The global insomnia market size reached US$ 5.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 2.69% during 2024-2032.
Insomnia is a sleep disorder that can lower energy levels and affect the mood, health, work performance, and overall life quality of an individual. Its common causes include stress, long travels, hectic work schedules, poor sleep habits, binge eating, and excessive consumption of nicotine, caffeine, and alcohol. It can also be associated with mental health disorders, such as post-traumatic stress, and the use of drugs like antidepressants for asthma or blood pressure and over-the-counter (OTC) for pain relief, allergy, and cold. Its treatment options, such as cognitive-behavioral therapy (CBT), OTC sleep aids, and prescription medications like Eszopiclone and Ramelteon, are currently available worldwide.
Insomnia Market Trends:
The coronavirus disease (COVID-19) pandemic generated unprecedented changes in lives, including social isolation and innumerable work challenges and family obligations. This acts as a major stressful event that impacted the sleep patterns of millions and strengthened the market growth. Moreover, medical conditions, such as chronic pain, cancer, diabetes, heart disease, asthma, gastroesophageal reflux disease (GERD), overactive thyroid, Parkinson's disease, and Alzheimer's disease, are usually linked with insomnia. Hence, the increasing number of individuals suffering from these ailments is driving the demand for insomnia medications. Apart from this, hormonal shifts during the menstrual cycle and menopause can lead to the risk of developing insomnia, which is contributing to the market growth. In addition, as changes in sleep patterns, activity, and health and the rising use of prescription drugs can increase the chance of insomnia among older people, the growing geriatric population globally is catalyzing the demand for insomnia medical treatment. Furthermore, increasing investments in testing new treatments, interventions, and tests to prevent, detect, treat, and manage insomnia are anticipated to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global insomnia market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapy type, drug class and distribution channel.
Breakup by Therapy Type:
Non-Pharmacological Therapy
Hypnotherapy
Cognitive Behavioral Therapy
Medical Devices
Others
Pharmacological Therapy
Prescription Sleep Aids
Over-The-Counter Sleep Aids
Breakup by Drug Class:
Antidepressants
Melatonin Antagonist
Benzodiazepines
Nonbenzodiazepines
Orexin Antagonist
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.
Key Questions Answered in This Report
- 1. What was the size of the global insomnia market in 2023?
- 2. What is the expected growth rate of the global insomnia market during 2024-2032?
- 3. What are the key factors driving the global insomnia market?
- 4. What has been the impact of COVID-19 on the global insomnia market?
- 5. What is the breakup of the global insomnia market based on the therapy type?
- 6. What is the breakup of the global insomnia market based on the drug class?
- 7. What are the key regions in the global insomnia market?
- 8. Who are the key players/companies in the global insomnia market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Insomnia Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Therapy Type
- 6.1 Non-Pharmacological Therapy
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Hypnotherapy
- 6.1.2.2 Cognitive Behavioral Therapy
- 6.1.2.3 Medical Devices
- 6.1.2.4 Others
- 6.1.3 Market Forecast
- 6.2 Pharmacological Therapy
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Prescription Sleep Aids
- 6.2.2.2 Over-The-Counter Sleep Aids
- 6.2.3 Market Forecast
7 Market Breakup by Drug Class
- 7.1 Antidepressants
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Melatonin Antagonist
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Benzodiazepines
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Nonbenzodiazepines
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Orexin Antagonist
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Hospital Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Drug Stores
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Online Pharmacies
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Astellas Pharma Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Aurobindo Pharma Limited
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.3 Biocodex
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Eisai Co. Ltd.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Mallinckrodt Pharmaceuticals
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 Merck & Co. Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Neurim Pharmaceuticals Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Pfizer Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Sanofi S.A.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Takeda Pharmaceutical Company Limited
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Vanda Pharmaceuticals Inc.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.1 Astellas Pharma Inc.
List of Figures
- Figure 1: Global: Insomnia Market: Major Drivers and Challenges
- Figure 2: Global: Insomnia Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Insomnia Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Insomnia Market: Breakup by Therapy Type (in %), 2023
- Figure 5: Global: Insomnia Market: Breakup by Drug Class (in %), 2023
- Figure 6: Global: Insomnia Market: Breakup by Distribution Channel (in %), 2023
- Figure 7: Global: Insomnia Market: Breakup by Region (in %), 2023
- Figure 8: Global: Insomnia (Non-Pharmacological Therapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Insomnia (Non-Pharmacological Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Insomnia (Pharmacological Therapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Insomnia (Pharmacological Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Insomnia (Antidepressants) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Insomnia (Antidepressants) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Insomnia (Melatonin Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Insomnia (Melatonin Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Insomnia (Benzodiazepines) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Insomnia (Benzodiazepines) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Insomnia (Nonbenzodiazepines) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Insomnia (Nonbenzodiazepines) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Insomnia (Orexin Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Insomnia (Orexin Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Insomnia (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Insomnia (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Insomnia (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Insomnia (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Insomnia (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Insomnia (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Insomnia (Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Insomnia (Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Global: Insomnia (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Global: Insomnia (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: North America: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: North America: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: United States: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: United States: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Canada: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Canada: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: Asia-Pacific: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: Asia-Pacific: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: China: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: China: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Japan: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Japan: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: India: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: India: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: South Korea: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: South Korea: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Australia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Australia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Indonesia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Indonesia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Europe: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Europe: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Germany: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Germany: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: France: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: France: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: United Kingdom: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: United Kingdom: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Italy: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Italy: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Spain: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Spain: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Russia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Russia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Latin America: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Latin America: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Brazil: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Brazil: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Mexico: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Mexico: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Middle East and Africa: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 79: Middle East and Africa: Insomnia Market: Breakup by Country (in %), 2023
- Figure 80: Middle East and Africa: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: Global: Insomnia Industry: SWOT Analysis
- Figure 82: Global: Insomnia Industry: Value Chain Analysis
- Figure 83: Global: Insomnia Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Insomnia Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Insomnia Market Forecast: Breakup by Therapy Type (in Million US$), 2024-2032
- Table 3: Global: Insomnia Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
- Table 4: Global: Insomnia Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
- Table 5: Global: Insomnia Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Insomnia Market: Competitive Structure
- Table 7: Global: Insomnia Market: Key Players
